Study of three study drugs in healthy adults
Treatments studied
Part of Heart & circulation, Hormones & metabolism clinical trials.
This trial tests how three study drugs interact with each other in healthy adults. It may help find safe doses for future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult aged 19 to 64 years.
- You must weigh at least 50 kg (or 45 kg for women).
- Your body mass index (BMI) must be between 18 and 30.
- You must not have taken part in another drug study in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how two study drugs, AD-2321 and AD-2322, interact with each other in the body and checks if they are safe for healthy adults. Taking part will help researchers learn more about these drugs for future use.
This study tests how two experimental medications (AD-236A and AD-236B) interact with each other in the body and checks that they are safe for healthy adults. It helps determine how these drugs should be dosed for future treatments.
This study tests a new medicine called AD-231 and compares it to taking three separate pills together. You would need to be in generally good health and within a certain age and weight range.
This study will compare two versions of a drug (called AD-117 and AD-117A) to see how your body processes them and whether they are safe. You would receive one version and then the other, to compare their effects.
This trial tests a new drug called AD-123 and compares it to taking two other drugs (AD-1231 and AD-1232) together. It is for healthy adults to see how the body handles the drugs and if they are safe.
This trial tests two experimental drugs in healthy adults to see how they interact with each other and to check their safety. It involves taking the drugs in a specific order over multiple days.
Hear when a new High blood pressure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.